EvA invites COPD patients (exsmokers) and healthy volunteers (age >45, never smokers or exsmokers) to become involved in the study, which includes various procedures carried out by certified physicians to assess lung health. Once enrolled, patients may withdraw from the study at any stage and this will not affect their future treatment.
Chronic obstructive pulmonary disease (COPD) is characterised by the destruction of alveoli in the lung (Emphysema) and the inflammation and thickening of airway walls (Airways disease). Patients may exhibit both of these symptoms or one alone. The consequences of COPD result in airway obstruction and the patient will have difficulty breathing. COPD is a global problem. In 2002 it was the fifth leading cause of death worldwide and it is projected to become the fourth leading cause of death in 2030.
WANT TO TAKE PART?